CNBC Television published this video item, entitled “What Merck’s treatment means for the company, vaccine makers” – below is their description.
Geoff Meacham, senior pharma analyst, BofA Securities, on what Merck’s new Covid treatment could mean for the company and the industry, as a whole. With CNBC’s Melissa Lee and the Fast Money traders, Tim Seymour, Karen Finerman, Steve Grasso and Nadine Terman.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.